Reactions to the proposed diagnostic criteria on Alzheimer’s disease from clinical neuropsychologists who specialize in dementia
Kevin Duff, Andrew M Kiselica, Marissa A. Gogniat, Unai Diaz‐Orueta, S Duke Han · 2025
Read Reactions to the proposed diagnostic criteria on Alzheimer’s disease from clinical neuropsychologists who specialize in dementia by Kevin Duff, Andrew M Kiselica, Marissa A. Gogniat, Unai Diaz‐Orueta, S Duke Han (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11713542.txt.
Description
Kevin Duff and co-authors survey dementia specialists about new biomarker-first rules for diagnosing Alzheimer's disease, in this 2025 paper. The Alzheimer's Association proposes defining the disease by biology alone, apart from symptoms. The shift worries clinicians who work with patients and families daily.
Sixty-one specialists from an international society group answered fifteen statements about the proposal. Ratings covered its purpose, fairness across groups, and access to biomarker testing. Every statement drew the full spread of opinion, from strong agreement to strong disagreement. On balance, scores leaned toward concern. The authors say rollout questions, including effects on existing inequities, remain open.
Catalog record
| CREATOR | Kevin Duff, Andrew M Kiselica, Marissa A. Gogniat, Unai Diaz‐Orueta, S Duke Han |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |